Fitch, Even, Tabin & Flannery® has many capabilities to assist pharmaceutical companies with all aspects of intellectual property development, protection, due diligence, clearance opinions, licensing and litigation. With attorneys and patent agents possessing undergraduate and advanced degrees in chemistry, biochemistry, chemical engineering and biology and related fields, we bring a formidable technical capability to clients in this field. Coupled with the diverse legal aptitude of the firm, Fitch Even is highly qualified to help pharmaceutical companies achieve their business objectives through effective use of the intellectual property laws.

The firm's clients in this field include multinational pharmaceutical companies, emerging generic pharmaceutical companies, and other smaller companies. We have considerable experience with the substantive and procedural aspects of the Hatch-Waxman Act relating to New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs). The firm has also handled patent infringement actions under the Hatch-Waxman Act.

In recent years, Fitch Even expanded its longstanding commitment to servicing the pharmaceutical industry by contributing the chapter entitled "Intellectual Property in Drug Discovery and Biotechnology" in Burger's Medicinal Chemistry and Drug Discovery. This work provides further insights into Fitch Even's comprehensive approach to procuring, managing, evaluating and enforcing patents in the pharmaceutical, biotechnology and medical fields.